22 Results for "

Solid tumours

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "Solid tumours" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-13432
CAS No.: 1256448-47-1
Purity:  99.34%
Synonyms: CHR-3996
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Nanatinostat (CHR-3996) is a potent, class I selective and orally active HDAC inhibitor with IC50s of 3 nM, 4 nM, and 7 nM for HDAC1, HDAC2, and HDAC3, respectively. Nanatinostat has low activity against HDAC5 (IC50 of 200 nM) and HDAC6 (IC50 of 2100 nM). Nanatinostat induces apoptosis in myeloma cells. Nanatinostat has potent anticancer effects, such as myeloma, advanced solid tumours and colorectal cancer .
loading...
    loading...
Cat. No.: HY-P99450
CAS No.: 2226393-85-5
Synonyms: IPH 5401; Anti-C5aR1 mAb

Target:  

Complement System

Research Areas:  

Inflammation/Immunology Cancer

Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .
loading...
    loading...
Cat. No.: HY-176761
CAS No.: 1033931-92-8
Research Areas:  

Cancer

NSC647889 is an apoptosis and autophagy inducer. NSC647889 induces apoptosis, inhibits mTOR pathway and abrogates DNA synthesis. NSC647889 triggers LC3-positive vesicle formation, modulates AKT and 4EBP1 phosphorylation and shows heightened caspase-3 activation in multicellular spheroids. NSC647889 can be used for the research of solid cancer tumour, head-neck carcinoma, and colorectal cancer .
loading...
    loading...
Cat. No.: HY-139678
CAS No.: 2839142-69-5
SC13 is an orally active, selective Flap structure-specific endonuclease 1 (FEN1) inhibitor and mu opioid receptor (MOR) activator. SC13 impairs DNA damage repair and induces apoptosis in cancer cells. SC13 activates cGAS-STING signaling, increases chemokine secretion, and promotes CAR-T cell infiltration at solid tumour sites. SC13 can be used for the research of solid tumours and pain .
loading...
    loading...
Cat. No.: HY-139453A
CAS No.: 2412580-47-1
Research Areas:  

Cancer

LP-284 is a potent DNA alkylating agent that kills solid tumours. LP-284 can be used in the studies of hematologic cancers with compromised DNA repair, such as mantle cell lymphoma (MCL) .
loading...
    loading...
Cat. No.: HY-P991469
Synonyms: MEDI-565

Research Areas:  

Cancer

AMG-211 (MEDI-565)i s a bispecific antibody targeting CD3E and CEACAM5/CEA/CD66e. AMG-211 can be used in Gastrointestinal cancer and Solid tumours research .
loading...
    loading...
Cat. No.: HY-P991348

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

BAT-1306 is a human monoclonal antibody (mAb) targeting PDCD1/PD-1/CD279. BAT-1306 can be used in Colorectal cancer and Solid tumours research .
loading...
    loading...
Cat. No.: HY-P991391

Research Areas:  

Cancer

COM902 is a human IgG4 monoclonal antibody (mAb) targeting TIGIT. COM902 enhances anti-tumor immune responses. COM902 can be used in Multiple myeloma, Solid tumours and Colorectal cancer research. Recommended isotype control: IgG4-lambda .
loading...
    loading...
Cat. No.: HY-P991390

Research Areas:  

Cancer

BAT-6021 is a human monoclonal antibody (mAb) targeting TIGIT. BAT-6021 can be used in Solid tumours research .
loading...
    loading...
Cat. No.: HY-P991438

Target:  

Interleukin Related

Research Areas:  

Cancer

XmAb-662 is a fusion protein targeting IL-12. XmAb-662 can be used in solid tumours research .
loading...
    loading...
Cat. No.: HY-128470
CAS No.: 91753-07-0
Synonyms: GR-30921
Target:  

Drug Derivative

Research Areas:  

Cancer

Mitoquidone (GR-30921) is is the first member of a group of pentacyclic pyrroloquinones. Mitoquidone shows good activity in a range of experimental solid tumour models. Mitoquidone can be used for the research of anti-cancer .
loading...
    loading...
Cat. No.: HY-P991605

Target:  

LAG-3

Research Areas:  

Cancer

HLX26 is a humanised anti-LAG-3 monoclonal antibody. HLX26 has antitumor activity especially advanced solid tumours. HLX26 can be used for lymphoma research .
loading...
    loading...
Cat. No.: HY-P991357

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

STT-001 is a human monoclonal antibody (mAb) targeting B7-H1/PD-L1/CD274. STT-001 can be used in Solid tumours research .
loading...
    loading...
Cat. No.: HY-P991367

Target:  

CD47

Research Areas:  

Cancer

ES004 is a human monoclonal antibody (mAb) targeting SIRPα/CD172a. ES004 enhances macrophage phagocytosis and induces potent T cell responses to promote tumor killing. ES004 can be used in Solid tumours research .
loading...
    loading...
Cat. No.: HY-P991344

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

AMP-224 is a fusion protein targeting PD-L2. AMP-224 specifically binds to PD-1 T cells (chronically stimulated/exhausted T cells). AMP-224 can be used in Colorectal cancer and Solid tumours research .
loading...
    loading...
Cat. No.: HY-P991354

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

GR-1405 is a human monoclonal antibody (mAb) targeting B7-H1/PD-L1/CD274. GR-1405 enhances cytotoxic T lymphocyte (CTL)-mediated antitumor immune responses against PD-L1-expressing tumor cells. GR-1405 can be used in Lymphoma and Solid tumours research .
loading...
    loading...
Cat. No.: HY-13432A
CAS No.: 1256448-48-2
Synonyms: CHR-3996 TFA
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Nanatinostat (CHR-3996) TFA is a potent, class I selective and orally active HDAC inhibitor with IC50s of 3 nM, 4 nM, and 7 nM for HDAC1, HDAC2, and HDAC3, respectively. Nanatinostat TFA has low activity against HDAC5 (IC50 of 200 nM) and HDAC6 (IC50 of 2100 nM). Nanatinostat TFA induces apoptosis in myeloma cells. Nanatinostat TFA has potent anticancer effects, such as myeloma, advanced solid tumours and colorectal cancer .
loading...
    loading...
Cat. No.: HY-P992315
Synonyms: PTZ-522

Target:  

TNF Receptor

Research Areas:  

Cancer

ASP1951 (PTZ-522) is a monoclonal antibody that targets GITR and is a GITR agonist. ASP1951 can be used for the research of advanced solid tumours .
loading...
    loading...
Cat. No.: HY-P992368

Target:  

TNF Receptor

Research Areas:  

Cancer

HLX51 is a regulatory T cell inhibitor and OX40/CD134/TNFRSF4 agonist with tumour growth inhibitory activity. HLX51 inhibits regulatory T cell differentiation and activity, relieves tumour microenvironment immunosuppression, enhances effector T cell function. HLX51 competitively binds OX40, activates OX40, promotes immune cell proliferation and T cell killing ability. HLX51 modulates immune cell function to inhibit tumour growth. HLX51 can be used for the research of advanced/metastatic solid tumours and lymphomas .
loading...
    loading...
Cat. No.: HY-P991349

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

GNR-051 is a human monoclonal antibody (mAb) targeting PDCD1/PD-1/CD279. GNR-051 can be used in Solid tumours research .
loading...
    loading...